Category Archives: Research
Treatment Resistant Depression: Case Report
rTMS treatment for Major Depressive Disorder MDD involves stimulation of the dorsolateral prefrontal cortex which plays an important role in cognitive function and mood.
Study Uses Non-invasive Technique To Help Veterans With Depression, Concussion
Promising studies using repetitive T to help veterans and active-duty service members living with depression, post-traumatic stress disorder (PTSD), and other lasting consequences of concussion.
Pilot Study: New Approach to Help Adults with Autism and Depression
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
Targeting Brain Circuits in TMS May Relieve Specific Symptoms of Depression
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
Intensive Brain Stimulation Lifts Depression In 90% of Patients
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
Large-Scale Analysis of Interindividual Variability in Theta-Burst Stimulation Data: Results From the ‘Big TMS Data Collaboration’
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
The Future Is Now? Rapid Advances by Brain Stimulation Innovation
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
Transcranial Magnetic Stimulation
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.